LYON, France, July 13, 2009 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it has retained Douglas Chinn, MD to assist and support U.S. investigational sites in enrolling, treating, and following patients in the U.S. ENLIGHT clinical trial. Dr. Chinn will work with the current team of expert advisers to liaise between EDAP and participating physicians in the trial.
